| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
PAVmed Inc.
13G/A
Amendment 2
PAVM · 70387R502
|
15.3% |
4/14/2026
Event 3/27/2026
|
|||
| Tasso Partners, LLC | 14.3% | ||||
| Dana Carrera | 15.3% | ||||
|
PAVmed Inc.
13G/A
Amendment 1
PAVM · 70387R502
|
14.3% |
4/3/2026
Event 3/27/2026
|
|||
| Tasso Partners, LLC | 14.3% | ||||
| Dana Carrera | 14.3% | ||||
|
Orchestra BioMed Holdings, Inc.
13G
OBIO · 68572M106
|
5.5% |
11/19/2025
Event 11/15/2025
|
|||
| Tasso Partners, LLC | 5.0% | ||||
| Dana Lorenzo | 5.5% | ||||
|
DarioHealth Corp.
13G/A
Amendment 2
DRIO · 23725P209
|
10.0% |
11/12/2025
Event 9/30/2025
|
|||
| Tasso Partners, LLC | 10.0% | ||||
| Dana Carrera | 10.0% | ||||
|
Super League Enterprise, Inc.
13G/A
Amendment 1
SLE · 86804F301
|
5.7% |
5/15/2025
Event 3/31/2025
|
|||
| Tasso Partners, LLC | 5.1% | ||||
| Dana Carrera | 5.7% | ||||
|
DarioHealth Corp.
13G/A
Amendment 1
DRIO · 23725P209
|
7.9% |
5/13/2025
Event 3/31/2025
|
|||
| Tasso Partners, LLC | 6.9% | ||||
| Dana Carrera | 7.9% | ||||
|
PAVmed Inc.
13G
PAVM · 70387R403
|
18.9% |
2/28/2025
Event 2/21/2025
|
|||
| Tasso Partners, LLC | 18.9% | ||||
| Dana Carrera | 18.9% | ||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.